Lanthanide(III) chelates as MRI contrast agents: A brief description

被引:14
|
作者
Rashid, H. Ur. [1 ]
Yu, K. [1 ]
Zhou, J. [1 ]
机构
[1] Huazhong Univ Sci & Technol, Sch Chem & Chem Engn, Wuhan 430074, Peoples R China
关键词
magnetic resonance imaging (MRI); gadolinium; relaxivity; nuclear relaxation; mean residence lifetime; contrast agents; hydration number; nephrogenic systemic fibrosis (NSF); NEPHROGENIC SYSTEMIC FIBROSIS; BLOOD-POOL AGENT; GADOLINIUM(III) COMPLEXES; WATER EXCHANGE; RELAXIVITY; RELAXATION; PHARMACOKINETICS; SENSITIVITY; STABILITY; CHEMISTRY;
D O I
10.1134/S002247661301037X
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Magnetic resonance imaging (MRI) has become a prominent imaging technique in medicine. Gadoliniumbased contrast agents are extensively used to enhance the contrast between normal and diseased tissues through MRI scans. The article illustrates the paramount significance of such contrast agents in MRI applications. Clinically approved contrast agents as well as those in trial period are discussed. Important parameters, i.e. hydration number, rotational correlation time, and mean residence lifetime, influencing the relaxivity (sensitivity) of such agents are described in detail. Various approaches towards relaxivity enhancement are discussed with appropriate examples from the recent literature. A decrease in the Gdwater proton distance results in significant relaxivity enhancement. A comprehensive classification and explanation of Gd3+-based contrast agents are presented. Each class is explained with suitable examples. The stability of contrast agents is dependent on their chemical structure. Future contrast agents need to be tissue specific of high relaxivity, low toxicity, and lower administered dose for in vivo use.
引用
收藏
页码:223 / 249
页数:27
相关论文
共 50 条
  • [31] Lanthanide(III) chelates for NMR biomedical applications
    Aime, S
    Botta, M
    Fasano, M
    Terreno, E
    CHEMICAL SOCIETY REVIEWS, 1998, 27 (01) : 19 - 29
  • [32] Cyclen lanthanide-based micellar structures for application as luminescent [Eu(III)] and magnetic [Gd(III)] resonance imaging (MRI) contrast agents
    Surender, Esther M.
    Comby, Steve
    Martyn, Sarah
    Cavanagh, Brenton
    Lee, T. Clive
    Brougham, Dermot F.
    Gunnlaugsson, Thorfinnur
    CHEMICAL COMMUNICATIONS, 2016, 52 (72) : 10858 - 10861
  • [33] Lanthanide(III) chelates for NMR biomedical applications
    Aime, S.
    Botta, M.
    Fasano, M.
    Terreno, E.
    Chemical Society Reviews, 27 (01):
  • [34] Chiral Pyclen-Based Heptadentate Chelates as Highly Stable MRI Contrast Agents
    Jian, Yong
    Mo, Gengshen
    Xu, Weiyuan
    Liu, Yao
    Zhang, Zhichao
    Ding, Yinghui
    Gao, Ruonan
    Xu, Jiao
    Zhu, Jiang
    Shu, Kun
    Yan, Zhihan
    Carniato, Fabio
    Platas-Iglesias, Carlos
    Ye, Fangfu
    Botta, Mauro
    Dai, Lixiong
    INORGANIC CHEMISTRY, 2024, 63 (18) : 8462 - 8475
  • [36] Gold Nanoparticles Functionalized with Gadolinium Chelates as High-Relaxivity MRI Contrast Agents
    Moriggi, Loick
    Cannizzo, Caroline
    Dumas, Eddy
    Mayer, Cedric R.
    Ulianov, Alexey
    Helm, Lothar
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (31) : 10828 - +
  • [37] GADOLINIUM(III) COMPLEX EQUILIBRIA - THE IMPLICATIONS FOR GD(III) MRI CONTRAST AGENTS
    JACKSON, GE
    WYNCHANK, S
    WOUDENBERG, M
    MAGNETIC RESONANCE IN MEDICINE, 1990, 16 (01) : 57 - 66
  • [38] The gadolinium(III)-water hydrogen distance in MRI contrast agents
    Caravan, P
    Astashkin, AV
    Raitsimring, AM
    INORGANIC CHEMISTRY, 2003, 42 (13) : 3972 - 3974
  • [39] EHPG iron(III) Complexes as Potential Contrast Agents for MRI
    Kuznik, Nikodem
    Jewula, Pawel
    Oczek, Lidia
    Kozlowicz, Sylwia
    Grucela, Artur
    Domagala, Wojciech
    ACTA CHIMICA SLOVENICA, 2014, 61 (01) : 87 - +
  • [40] Manganese-Enhanced MRI Contrast Agents: From Small Chelates to Nanosized Hybrids
    Kueny-Stotz, Marie
    Garofalo, Antonio
    Felder-Flesch, Delphine
    EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2012, (12) : 1987 - 2005